Macrogenics Inc SEC filings MGNX
Macrogenics Inc has 944 filings in SEC EDGAR's recent list, going back to Nov 12, 2003. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | May 19, 2026 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEF 14A | Proxy statement | Apr 11, 2025 | May 21, 2025 |
| DEFA14A | Additional proxy material | Apr 8, 2024 | — |
| DEF 14A | Proxy statement | Apr 8, 2024 | May 21, 2024 |
| DEFA14A | Additional proxy material | Apr 19, 2023 | — |
| DEFA14A | Additional proxy material | Apr 17, 2023 | — |
| DEF 14A | Proxy statement | Apr 17, 2023 | May 31, 2023 |
| DEFA14A | Additional proxy material | Apr 8, 2022 | — |
| DEF 14A | Proxy statement | Apr 8, 2022 | May 19, 2022 |
| DEFA14A | Additional proxy material | Apr 2, 2021 | — |
| DEF 14A | Proxy statement | Apr 2, 2021 | May 13, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEFA14A | Additional proxy material | Apr 3, 2020 | — |
| DEF 14A | Proxy statement | Apr 3, 2020 | May 14, 2020 |
| PRE 14A | Preliminary proxy statement | Mar 23, 2020 | May 14, 2020 |
| DEF 14A | Proxy statement | Apr 5, 2019 | May 16, 2019 |
| DEF 14A | Proxy statement | Apr 6, 2018 | May 17, 2018 |
| DEF 14A | Proxy statement | Apr 4, 2017 | May 18, 2017 |
| DEF 14A | Proxy statement | Apr 7, 2016 | May 18, 2016 |
| DEFA14A | Additional proxy material | Apr 9, 2015 | — |
| DEF 14A | Proxy statement | Apr 9, 2015 | May 20, 2015 |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jun 5, 2014 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MGNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1125345
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.